Physical and Rehabilitation Medicine – Functional Assessment, Restorative Therapies

Definition and Core Concept

This article defines Physical and Rehabilitation Medicine (PRM) as the medical specialty focused on improving and restoring functional ability and quality of life for individuals with physical impairments or disabilities affecting the nervous, musculoskeletal, cardiopulmonary, or other body systems. PRM encompasses diagnosis, medical management, and coordination of rehabilitation interventions including physical therapy, occupational therapy, speech-language therapy, prosthetics and orthotics, and assistive technology. Core features: (1) functional assessment (measuring activities of daily living – ADLs, mobility, communication, cognition, participation), (2) goal setting (patient-centred, measurable, time-limited functional outcomes), (3) multidisciplinary team approach (physiatrist, physiotherapist, occupational therapist, speech therapist, rehabilitation nurse, psychologist, social worker), (4) therapeutic interventions (therapeutic exercise, neurodevelopmental techniques, balance training, gait re-education, task-specific training), (5) adaptive equipment and environmental modifications (wheelchairs, walkers, home ramps, bathroom grab bars). The article addresses: stated objectives of PRM; key concepts including neuroplasticity, activity limitation, participation restriction, and task-oriented training; core mechanisms such as constraint-induced movement therapy, locomotor training, and botulinum toxin for spasticity; international comparisons and debated issues (intensity of rehabilitation, early mobilisation, rehabilitation outcome measurement); summary and emerging trends (robotic exoskeletons, virtual reality rehabilitation, telerehabilitation); and a Q&A section.

1. Specific Aims of This Article

This article describes physical and rehabilitation medicine without endorsing specific protocols. Objectives commonly cited: maximising independence and quality of life for individuals with disabling conditions, reducing caregiver burden, preventing secondary complications (contractures, pressure injuries, falls, deconditioning), facilitating community reintegration, and reducing long-term healthcare costs. The article notes that PRM serves diverse populations including those with stroke, spinal cord conditions, traumatic brain injury, amputation, joint replacement, multiple sclerosis, Parkinson’s disease, and persistent musculoskeletal discomfort.

2. Foundational Conceptual Explanations

Key terminology:

• Neuroplasticity: The brain’s ability to reorganise synaptic connections and neural pathways in response to learning, experience, or injury following damage. Basis for rehabilitation: task-specific repetitive practice drives cortical reorganisation.
• Activities of daily living (ADLs): Basic self-care tasks (bathing, dressing, toileting, transferring, continence, feeding). Instrumental ADLs (IADLs) include more complex activities (managing finances, transportation, shopping, meal preparation, housework, medication management).
• Constraint-induced movement therapy (CIMT): Restraint of the less-affected limb combined with intensive training of the more-affected limb for individuals with hemiparesis (post-stroke). Improves upper extremity function with moderate to large effect sizes (d=0.5-0.8) for selected patients.
• Spasticity: Velocity-dependent increase in muscle tone due to hyperexcitability of stretch reflex; common after upper motor neuron conditions (stroke, spinal cord injury, cerebral palsy). Managed with stretching, splinting, oral medications (baclofen, tizanidine), and focal treatments (botulinum toxin injections).
• Locomotor training (body-weight supported treadmill training – BWSTT): Technique using harness suspension and treadmill (with or without robotic assistance) to retrain walking patterns. Improves walking speed and endurance for incomplete spinal cord injury and post-stroke (moderate evidence, d=0.3-0.5).

International Classification of Functioning, Disability and Health (ICF, WHO): Framework for describing functioning and disability at body functions/structures, activities, and participation levels, considering environmental and personal factors.

3. Core Mechanisms and In-Depth Elaboration

Rehabilitation team members and roles:

• Physiatrist (rehabilitation physician): Medical diagnosis, spasticity management (botulinum toxin, intrathecal baclofen), medication management, coordination of care.
• Physical therapist (PT): Gross motor function (mobility, gait, balance, strength, endurance, transfers).
• Occupational therapist (OT): Fine motor function, ADLs, IADLs, cognitive retraining, adaptive equipment, home safety.
• Speech-language pathologist (SLP): Communication (aphasia, dysarthria, cognitive-communication), swallowing (dysphagia), cognition.
• Rehabilitation nurse: Skin care, bowel/bladder management, medication administration, family education, prevention of secondary complications.
• Prosthetist/orthotist: Design and fitting of artificial limbs (prostheses) and supportive braces (orthoses).
• Psychologist: Mood management (depression, anxiety common after disability), cognitive assessment, adjustment counselling.

Rehabilitation settings (by intensity):

• Acute inpatient rehabilitation (IRF): 3+ hours of therapy daily, multidisciplinary, for patients with medical stability and potential for significant functional gains. Average length of stay 10-30 days.
• Skilled nursing facility (subacute rehabilitation): 1-2 hours of therapy daily, slower pace, for patients who cannot tolerate intensive therapy or have slower expected gains.
• Outpatient rehabilitation: 1-3 sessions weekly, for individuals living in community.
• Home health rehabilitation: Therapy delivered in patient’s residence (for those unable to travel).

Evidence-based interventions (selected):

• Stroke rehabilitation: Early mobilisation (within 24-48 hours) reduces complications. CIMT improves arm function (d=0.6) for patients with some wrist/finger extension. Locomotor training improves walking speed (0.1-0.2 m/s increase) comparable to overground walking training.
• Spinal cord injury (SCI): Intensive locomotor training improves walking for incomplete SCI (ASIA C/D). Respiratory muscle training improves vital capacity and reduces respiratory complications. Bowel and bladder programmes reduce hospitalisations for urinary tract conditions (by 40-60%).
• Joint replacement (hip/knee): Pre-operative exercise (prehabilitation) reduces length of stay by 1-2 days. Early post-operative mobilisation (day of surgery) improves function and reduces complications (deep vein thrombosis, pulmonary complications).
• Parkinson’s disease: LSVT BIG (amplitude-based training) improves gait speed, balance, and limb movement amplitude (d=0.5-0.7 compared to no exercise). Tai chi reduces falls (by 30-50%).

Outcome measurement in rehabilitation:

• Functional Independence Measure (FIM): 18-item ADL and cognition scale (USA, many countries).
• Barthel Index (ADL measure, widely used).
• 10-Metre Walk Test (gait speed).
• 6-Minute Walk Test (endurance).
• Berg Balance Scale (balance).

4. Comprehensive Overview and Objective Discussion

International rehabilitation systems:

Debated issues:

1. Intensity of therapy (dose-response relationship): Higher intensity (e.g., 3-5 hours/day vs 1-2 hours/day) is associated with better outcomes for stroke, spinal cord injury, and traumatic brain injury. However, high-intensity programmes require more staff, facilities, and patient tolerance. Optimal dose is condition- and individual-specific.
2. Early mobilisation (starting therapy within 24-48 hours of admission): For stroke, early mobilisation improves discharge disposition (home vs institution). For post-operative orthopaedic patients, day-of-surgery mobilisation reduces length of stay (1-2 days). For critically ill patients, early mobilisation reduces ICU and hospital length of stay (2-4 days).
3. Rehabilitation outcome measurement variability: Many different scales, making cross-study comparisons challenging. Standardisation efforts (e.g., International Classification of Functioning – ICF core sets) facilitate data aggregation and meta-analysis.
4. Access disparities: Individuals with lower income, rural residence, and minority backgrounds have reduced access to inpatient rehabilitation (20-40% lower admission rates in some studies), due to coverage limitations, facility availability, and referral patterns.

5. Summary and Future Trajectories

Summary: Physical and rehabilitation medicine improves function for individuals with disabling conditions through multidisciplinary goal-oriented interventions. Constraint-induced movement therapy (post-stroke) and locomotor training (spinal cord injury, stroke) are evidence-based. Early mobilisation improves outcomes. Higher therapy intensity is associated with better outcomes. Access disparities exist.

Emerging trends:

• Robotic exoskeletons (for gait training in spinal cord injury and stroke): Powered lower limb devices enabling overground walking. Randomised trials show modest improvements in walking speed and endurance compared to conventional locomotor training; cost-effectiveness not yet established ($50,000-150,000 per device).
• Virtual reality rehabilitation (VR) for upper extremity and balance: Immersive or non-immersive computer-generated environments for task practice. Meta-analyses show small additional benefit (d=0.2-0.3) over conventional therapy for post-stroke arm function.
• Telerehabilitation (remote therapy via videoconference): Comparable outcomes to in-person for selected conditions (stroke (chronic phase), Parkinson’s disease, joint replacement follow-up) in randomised trials. Acceptable to patients; reduces travel burden.
• Neuromodulation (transcranial magnetic stimulation – TMS, transcranial direct current stimulation – tDCS): Non-invasive brain stimulation combined with rehabilitation enhances neuroplasticity. For post-stroke motor recovery, tDCS shows small effect (d=0.2) on impairment measures; not yet FDA-approved; research ongoing.

6. Question-and-Answer Session

Q1: How long after a stroke should rehabilitation begin?
A: As soon as medically stable (typically within 24-48 hours). Very early mobilisation (within 24 hours) is generally safe and beneficial, but avoid sitting on the edge of the bed if blood pressure control is compromised. Intensive rehabilitation continues for months to years.

Q2: What is the role of botulinum toxin in rehabilitation medicine?
A: Botulinum toxin type A is injected into overactive muscles to reduce focal spasticity (e.g., elbow flexors, ankle plantar flexors) for 2-4 months. Reduces tone, improves passive range of motion, reduces pain, and facilitates stretching and splinting. It does not replace active task practice but makes it easier.

Q3: Can individuals with complete spinal cord injury walk again?
A: For complete SCI (no motor or sensory function below the level of injury), volitional walking is not restored. However, exoskeletons and functional electrical stimulation (FES) cycling allow standing and walking with assistance. Incomplete SCI (some preserved function) benefit from locomotor training to improve walking ability.

Q4: How is spasticity distinguished from contracture, and how are they managed?
A: Spasticity is velocity-dependent increase in tone (resistance to rapid stretch). Contracture is fixed shortening of muscle or joint capsule (resistance persists regardless of stretch speed). Spasticity is treated with stretching, splinting, and medications/injections. Contracture requires prolonged stretching, serial casting, or surgical release.

https://www.who.int/classifications/icf/
https://www.aapmr.org/ (American Academy of Physical Medicine and Rehabilitation)
https://www.mskcc.org/rehabilitation
https://www.cochrane.org/evidence/rehabilitation